Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1

Chengchun Shen, Wenzhe Wang, Li-jiang Tao, Bing Liu, Zhengming Yang, Huimin TaoInternational Journal of Molecular Medicine 2013 · DOI

Abstract

Cisplatin (DDP) is a cornerstone of chemotherapy for osteosarcoma (OS), yet acquired resistance frequently undermines its clinical efficacy. This study investigates the mechanisms of drug resistance in OS by examining the interplay between apoptosis and autophagy. Using a panel of four OS cell lines (MG-63, U-2OS, MNNG/HOS, and Saos-2), we demonstrate that the highly resistant Saos-2 line evades DDP-induced apoptosis by activating a protective autophagic response. Inhibition of this process with chloroquine (CQ) successfully sensitized Saos-2 cells to DDP, leading to increased cell death. Furthermore, we identified a characteristic temporal regulation of the autophagic marker p62/SQSTM1 during treatment. These findings suggest that targeting autophagy with agents like chloroquine represents a promising therapeutic strategy for overcoming chemoresistance in osteosarcoma.

Introduction

Osteosarcoma (OS) remains the most prevalent primary malignant bone tumor, particularly among children and adolescents. While the introduction of cisplatin (DDP)-based multi-agent chemotherapy has significantly improved survival rates, the development of "acquired resistance" remains a major obstacle, often leading to treatment failure and metastasis.

A critical factor in drug resistance is the cell's ability to bypass programmed cell death, or apoptosis. Recent research has highlighted autophagy—a conserved catabolic process for degrading damaged organelles and proteins—as a potential survival mechanism in cancer cells under therapeutic stress. Depending on the context, autophagy can either promote cell death or act as a protective "shield." This study aims to clarify the role of autophagy in DDP-resistant OS cells and evaluate whether pharmacological inhibition of autophagy can restore drug sensitivity.

Materials and Methods

The researchers utilized four human OS cell lines: MG-63, U-2OS, MNNG/HOS, and Saos-2. Cell viability following DDP treatment (0–50 µM) was assessed using the Cell Counting Kit-8 (CCK-8) assay. Apoptosis was quantified via flow cytometry using Annexin V-FITC/PI staining and by monitoring caspase-3 cleavage through Western blotting.

To track autophagic activity, cells were transfected with a green fluorescent protein (GFP)-microtubule-associated protein 1 light chain 3 (LC3) expression vector to visualize autophagosome formation (puncta). Electron microscopy (EM) provided high-resolution morphological confirmation of autophagic vesicles. Molecular markers of autophagy, including the conversion of LC3-I to LC3-II and levels of the cargo protein p62/SQSTM1, were analyzed by Western blot. Finally, chloroquine (CQ) was employed as a lysosomal inhibitor to block the late stages of the autophagic flux.

Results

Differential Sensitivity and Apoptotic Response

The OS cell lines exhibited markedly different responses to cisplatin. MG-63, U-2OS, and MNNG/HOS cells showed dose-dependent decreases in viability and significant induction of apoptosis. In contrast, Saos-2 cells demonstrated high resistance, maintaining high viability even at 20 µM DDP.

Figure 1: Differential response of osteosarcoma cell lines to cisplatin treatment. (A) Cell viability measured by absorbance. (B) Western blot analysis of caspase-3 activation. (C) Flow cytometry analysis of apoptosis using Annexin V-FITC/PI staining.

As shown in Figure 1, while sensitive lines like U-2OS exhibited clear caspase-3 cleavage (P17 fragment) and a shift toward the Annexin V-positive apoptotic quadrants, Saos-2 cells showed neither significant caspase activation nor apoptotic shifts, confirming their resistant phenotype.

Induction of Protective Autophagy in Resistant Cells

In the absence of apoptosis, Saos-2 cells treated with DDP showed a dramatic increase in autophagic markers. GFP-LC3 puncta increased from approximately 2 per cell in controls to 16 per cell following 20 µM DDP treatment. Electron microscopy confirmed the presence of numerous autophagosomes containing cytoplasmic debris and mitochondria.

The study also observed a unique temporal pattern for the p62/SQSTM1 protein. Levels dropped sharply within the first hour of DDP exposure, indicating an immediate activation of autophagic degradation, followed by a rapid recovery. This "dip and recovery" suggests a robust homeostatic response that may contribute to the survival of resistant cells.

Sensitization via Autophagy Inhibition

To test if autophagy was indeed protective, the researchers combined DDP with chloroquine (CQ). In Saos-2 cells, the addition of 20 µM CQ significantly enhanced the cytotoxic effects of DDP (p < 0.001). By blocking the lysosomal degradation of autophagic cargo, CQ effectively disrupted the survival mechanism, forcing the resistant cells toward cell death.

Discussion and Conclusion

This study provides evidence that autophagy serves as a critical survival mechanism in DDP-resistant osteosarcoma cells. While DDP successfully triggers apoptosis in sensitive OS lines, resistant lines like Saos-2 pivot to autophagy to maintain cellular integrity under stress. The regulation of p62/SQSTM1 appears central to this adaptive response.

The finding that chloroquine can successfully sensitize resistant cells to cisplatin has significant clinical implications. Repurposing existing autophagy inhibitors or developing targeted monoclonal antibodies against autophagic regulators could offer a new avenue for treating patients with chemoresistant osteosarcoma. Future research should focus on validating these findings in vivo and mapping the upstream signaling pathways, such as mTOR or AMPK, that coordinate this protective autophagic flux.

Summary updated

Abstract

Cisplatin (DDP) is one of the most effective chemotherapeutic drugs against osteosarcoma (OS), the most common malignant bone-specific tumor. However, the acquired resistance to DDP limits its effectiveness in tumor treatment. In this study, in order to elucidate the mechanisms of drug resistance in cancer cells, we investigated cell death induced by DDP in OS cells. We evaluated the contribution of autophagy in the process of drug resistance in a panel of four OS cell lines, MG-63, U-2OS, MNNG/HOS and Saos-2. The cells were treated with DDP (0-50 µM) for 48 h and then cell vaibility was assessed using the Cell Counting kit-8 (CCK-8). Apoptosis was detected by flow cytometry and the green fluorescent protein (GFP)-microtubule-associated protein 1 light chain 3 (LC3) expression vector was used to visualize the formation of autophagic vesicles. Our results demonstrated that autophagy was induced by DDP in the drug-resistant cell line, Saos-2, which does not respond to DDP with apoptosis. DDP-induced autophagy protected the Saos-2 cells from apoptotic cell death. Moreover, the inhibition of autophagy by chloroquine, an inhibitor of lysosomal proteases, accelerated the DDP-induced cell death in Saos-2 cells. We also found that during DDP treatment, the protein expression level of the autophagic regulator, p62/sequestosome 1 (SQSTM1), decreased during the first hour of treatment, followed by a rapid recovery. Therefore, our data suggest a potential clinical therapy by targeting autophagy with chloroquine or monoclonal antibodies for the treatment of drug-resistant OS.
BibTeX
@article{shen2013chloroquine,
  author = {Chengchun Shen and Wenzhe Wang and Li-jiang Tao and Bing Liu and Zhengming Yang and Huimin Tao},
  title = {{Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1}},
  journal = {International Journal of Molecular Medicine},
  year = {2013},
  doi = {10.3892/ijmm.2013.1399},
}
Figure